Radiopharmaceutical added to stereotactic radiation can delay prostate cancer progression
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a radiopharmaceutical drug before targeted ...
Sep 28, 2025
0
25









